← back to search

Feng Li

Changchun University of Science and Technology · CN
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Hepatitis B Virus Studies, COVID-19 Clinical Research Studies, and Hepatitis C virus research.
h-index
38
citations
6,502
works
243
NIH funding
primary concept
email

Recent publications

Modeling the pathogenic infection of mpox virus clade IIb in type I and II interferon pathway double deficient mice
hLife 2025cited by 6position: contributordoi
Deciphering the Molecular Adapting Mechanism of Lactic Acid-Tolerant Saccharomyces cerevisiae Through Genomic and Transcriptomic Analysis
Foods 2025cited by 2position: middledoi
Clinical prognostic value of TTV and HCMV but not EBV for outcomes in hospitalized HIV-positive patients
Biosafety and Health 2025cited by 2position: contributordoi
Unilateral biportal endoscopic with modified arcocristectomy for pinching cervical spondylotic myelopathy: surgical technique and early experiences
Frontiers in Surgery 2025cited by 1position: middledoi
Epidemiological characteristics of Circovirus Human infection in hospitalized patients in a representative infectious disease hospital in Guangzhou, China, from Feb 2023 to Dec 2024.
2025cited by 1position: contributordoi
Detectable Hepatitis B Virus (HBV) PreS Deletion Mutants at Baseline Predicted Delayed Immune Reconstitution and Increased Inflammation in People With Human Immunodeficiency Virus and HBV Coinfection Undergoing Long-term Antiretroviral Therapy.
2025cited by 1position: contributordoi
A hepatitis B virus-free cccDNA-producing stable cell for antiviral screening.
2025cited by 0position: contributordoi
Multimodal characterization of the responsiveness of eight hepatitis D virus genotype isolates to interferon-alpha treatment.
2025cited by 0position: contributordoi
A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice
Nature Communications 2024cited by 40position: middledoi
A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice.
2024cited by 30position: contributordoi
Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies.
2024cited by 17position: contributordoi
Nasal mucosal secretory immunoglobulin A but not serum antibodies is resistant to Omicron evasion
hLife 2024cited by 8position: contributordoi
Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023.
2024cited by 7position: contributordoi
Improvement in the 95-95-95 Targets Is Accompanied by a Reduction in Both the Human Immunodeficiency Virus Transmission Rate and Incidence in China.
2024cited by 7position: contributordoi
Clinical and pathogen features of COVID-19-associated infections during an Omicron strain outbreak in Guangzhou, China.
2024cited by 5position: contributordoi
Surveillance of avian influenza viruses in Hebei Province of China from 2021 to 2023: Identification of a novel reassortant H3N3.
2024cited by 4position: contributordoi
Full genomic sequence characterization of the chikungunya virus from an imported case with serum viral concentration below culturable level.
2024cited by 4position: contributordoi
Clinical characteristics, viral dynamics, and antibody response of monkeypox virus infections among men with and without HIV infection in Guangzhou, China.
2024cited by 3position: contributordoi
Identification of a novel HIV-1 third-generation circulating recombinant form (CRF126_0755) in Guangdong, China.
2024cited by 3position: contributordoi
Lack of Resistance Mutations to the Novel HIV-1 Capsid Inhibitor Lenacapavir Among People Living with HIV in Guangdong, China.
2024cited by 3position: contributordoi
Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV-co-infected patients with HBsAg loss.
2024cited by 3position: contributordoi
Molecular genetic characterization analysis of a novel HIV-1 circulating recombinant form (CRF156_0755) in Guangdong, China.
2024cited by 2position: contributordoi
Prevalence of bacteria, fungi, and virus coinfections with SARS-CoV-2 Omicron variant among patients with severe COVID-19 in Guangzhou, China, winter 2022.
2024cited by 1position: contributordoi
Genetic characteristics of a novel HIV-1 circulating recombinant form (CRF128_07B) identified among MSM in Guangdong Province, China.
2024cited by 1position: contributordoi
Risk factors for high‐stage histological chorioamnionitis among pregnancies with cervical incompetence
Journal of obstetrics and gynaecology research 2024cited by 0position: middledoi
Modeling HBV Infection and Therapy in Immunodeficient NOD-Rag1-/-IL2RgammaC-null (NRG) Fumarylacetoacetate Hydrolase (FAH) Knockout Mice with Human Chimeric Liver.
2024cited by 0position: contributordoi
Intra- vs. Interhost Evolution of SARS-CoV-2 Driven by Uncorrelated Selection—The Evolution Thwarted
Molecular Biology and Evolution 2023cited by 36position: middledoi
Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants.
2023cited by 18position: contributordoi
Intra- vs. Interhost Evolution of SARS-CoV-2 Driven by Uncorrelated Selection-The Evolution Thwarted.
2023cited by 17position: contributordoi
Drug Resistance Profile Among HIV-1 Infections Experiencing ART with Low-Level Viral Load in Guangdong China During 2011-2022: A Retrospective Study.
2023cited by 13position: contributordoi

Grants

EPSCoR Research Fellows: NSF: Heterogeneous Integration of Wide Bandgap Semiconductor Chips for High Temperature Applications
NSF2429402$299,9382025–2026PIRePORTER
REU Site: Enhancing Undergraduate Experiences in Data and Mobile Cloud Security
NSF2431725$469,9992024–2027PIRePORTER
REU Site: Enhancing Undergraduate Experiences in Data and Mobile Cloud Security
NSF2349233$469,9992024–2024PIRePORTER
REU Site: Enhancing Undergraduate Experiences in Mobile Cloud and Data Security
NSF1852105$411,0002018–2024PIRePORTER
REU Site: Enhancing Undergraduate Research Experiences in Mobile Cloud Security
NSF1560020$395,0002016–2022PIRePORTER
Student Travel Support for the MobiHoc (ACM International Symposium on Mobile Ad Hoc Networking and Computing) 2014 Conference
NSF1432905$15,0002014–2015PIRePORTER
SBIR Phase II: ION Gate Membrane For High Performance Redox Flow Batteries
NSF1329730$601,1162013–2016PIRePORTER
REU Site: Enhancing Undergraduate Experience in Mobile Computing Security
NSF1262984$359,9642013–2017PIRePORTER
SBIR Phase I: ION Gate Membrane For High Performance Redox Flow Batteries
NSF1142695$149,3802012–2012PIRePORTER
SBIR Phase I: A Novel Membrane for Hydrogen Separation
NSF0610572$99,9232006–2007PIRePORTER
SBIR Phase I: Enhanced Organic Electroluminescent Display
NSF9860356$99,7331999–1999PIRePORTER

Frequent collaborators

· 24 papers (2019–2025)Ling Chen · Indiana University School of Medicine9 papers (2021–2024)Fengyu Hu · University of North Carolina at Chapel Hill9 papers (2020–2025) · 8 papers (2020–2025)Jingrong Shi · Guangzhou Medical University6 papers (2022–2025)Liqiang Feng · Guangzhou Regenerative Medicine and Health Guangdong Laboratory5 papers (2021–2024)Linbing Qu · SpringerNature3 papers (2021–2024)Xinwen Chen · Nanjing Normal University3 papers (2022–2024)Xiaoli Xiong · First Affiliated Hospital of Soochow University3 papers (2022–2024)Wenhua Liang · Hebei Medical University3 papers (2020–2021)Wei‐jie Guan · Zero to Three2 papers (2021–2024)Junhua Li · Tsinghua University2 papers (2020–2021)Jinxin Liu · 2 papers (2022–2022) · 2 papers (2023–2025)Xiaoping Tang · Immune Regulation (United Kingdom)2 papers (2023–2023) · 2 papers (2023–2023)Longqi Liu · Zhejiang University2 papers (2022–2023)Jun He · Elsevier, Inc.2 papers (2022–2023)Chuanyu Liu · Erasmus University Rotterdam2 papers (2022–2023)F. Xiao‐Feng Qin · Chongqing University2 papers (2019–2019)